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Abstract 
This study tested the hypothesis that oxidative stress could be an underlying mechanism 
for APs-induced ovarian cytotoxicity and reproductive dysfunction. Rat ovarian theca interstitial 
cells (TICs) were isolated and treated with four APs [chlorpromazine (CPZ), haloperidol (HAL), 
risperidone (RIS) and clozapine (CLZ)]. MTT assay was used to test the effects of these 
antipsychotics on TICs viability and to estimate their 50% inhibitory concentrations (IC50s). The 
effects of APs (IC50s and 1µM concentrations) on the activities of caspases-3, -8 and -9, reactive 
oxygen species (ROS) production, total intracellular glutathione and lipid peroxidation (LPO) in 
TICs were assessed. The effect of antioxidants (reduced glutathione (GSH) and quercetin) on the 
APs-induced cytotoxicity on TICs was investigated. MTT assay showed all APs to reduce TICs 
viability. CPZ, HAL and CLZ significantly increased the activity of caspases-3, -8 and -9 
(P<0.0001, <0.0001 and <0.01, respectively). All APs at IC50s significantly (P<0.0001) increased 
ROS production, decreased total intracellular glutathione and increased LPO. MTT assay in the 
presence of antioxidants (reduced GSH (5mM) or quercetin (50mM)) showed each antioxidant to 
significantly inhibit the effects of APs at their IC50s on TICs viability. In conclusion, oxidative 
stress seems to be a possible mechanism for APs-induced ovarian and reproductive toxicity. 
 
 
Keywords: Antipsychotics, Oxidative stress, reproductive toxicity, antioxidants 
 
Abbreviations: APs, Antipsychotics; CPZ, Chlorpromazine; CLZ, Clozapine; HAL, Haloperidol; 
LPO, lipid peroxidation; ROS, reactive oxygen species; RIS, Risperidone; TICs, Theca 
interstitial cells; TBA, Thiobarbituric acid. 
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1. Introduction  
Most psychotic patients require life-long treatment with antipsychotics (APs) (Peuskens et 
al., 1998; Dickson and Glazer, 1999). Unfortunately, this treatment has been associated with a 
wide range of side effects such as abnormal movements, weight gain, diabetes and reproductive 
disorders. Between 15% and 97% of women, receiving APs have been reported to develop 
menstrual irregularities or amenorrhea (Santoni and Saubadu, 1995; Crismon and Dorson, 1997). 
Although typical APs are generally believed to be more toxic than the atypical (second-
generation) APs (Üçok and Gaebel, 2008), reproductive toxicity seems to be similar in the two 
groups of APs (Murke et al., 2011). 
It has been suggested that APs-induced hyperprolactinemia, via inhibition of dopamine 
action at D2 receptors in the tuberoinfundibular system, is the main cause for the associated 
reproductive disorders. Wong and Seeman (2007) reported hyperprolactinaemia in 57% of 
patients receiving typical APs. However, atypical APs were found to have no effect on serum 
prolactin levels with the exception of risperidone, which has been reported to increase circulating 
prolactin, similar to the typical APs (Halbreich et al., 2003; Aboraya et al., 2004). On the other 
hand, Lee and Kim (2006) found no correlation between plasma prolactin levels and menstrual 
irregularities. Furthermore, Canuso et al. (2002) found similar rates of reproductive dysfunction 
and ovarian hormone values in women with and without APs-induced hyperprolactinemia. 
Moreover, irrespective of the AP type or the prolactin status, APs were associated with reduced 
peak peri-ovulatory estradiol levels. Therefore, APs-induced hyperprolactinemia cannot fully 
explain reproductive toxicity of APs.  
We have recently shown APs to induce cytotoxic effects in rat’s ovarian theca interstitial 
cells as evidenced by inhibition of mitochondrial bioenergetics (Elmorsy et al., 2017). 
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Furthermore, several in-vitro (Contreras-Shannon et al., 2013; Antherieu et al., 2013; Elmorsy et 
al., 2014) and in-vivo (Shivakumar and Ravindranath, 1992; Parikh et al., 2003; Martins et al., 
2008) studies have shown APs to induce oxidative stress in non-reproductive cells. Moreover, 
our group has provided evidence that oxidative stress plays a role in APs-induced toxicity in 
human brain microvascular endothelial cells (Elmorsy et al., 2014).  
Based on the above, we hypothesized oxidative stress as a possible underlying mechanism 
of APs-induced ovarian theca cell toxicity with subsequent reproductive dysfunction. In order to 
test this hypothesis, rat’s ovarian theca interstitial cells (TICs) were isolated and used as a model 
to investigate the effects of APs. Four APs were chosen for the present study [Two typical; 
chlorpromazine (CPZ) and haloperidol (HAL) and two atypical; risperidone (RIS) and clozapine 
(CLZ)]. Theses APs, which are commonly used in clinical practice, are well known for their 
reproductive adverse effects (Spitzer et al., 1998; Feldman and Goldberg, 2002; Knegtering et 
al., 2003). The main aim of this study was to investigate the cytotoxic effects of APs on rat’s 
TICs and to determine the possible role of oxidative stress in this toxicity.    
2. Materials and methods 
2.1. Chemicals and media 
Chemicals, reagents and drugs, used in this study, were purchased from Sigma-Aldrich 
(Poole, UK) unless another source is specified. All stock solutions of drugs were made in DMSO 
(vehicle). Media and fetal calf serum (FCS) were purchased from Gibco (Grand Island, NY). 
Caspase activities were assessed by BD ApoAlert caspase fluorescent assay kits (Clontech 
Laboratories, Palo Alto, CA).  
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2.2. Animals 
Female Sprague-Dawley rats were housed in air-conditioned rooms, which were 
illuminated 14 h/day. Experiments were conducted in accordance with the guidelines for United 
Kingdom laboratory animals' use. The protocol has been approved by the Institutional Research 
Animal Committee, Mansoura University, Egypt. 
2.3. Theca interstitial cell isolation and culture: 
In order to obtain rat pre-ovulatory follicles, immature 23- to 24-day-old rats were injected 
th equine chorionic gonadotropin (10 IU) between 09:00 and 09:30 h to enhance multiple 
follicular development. Rats were then anesthetized and their ovaries removed. Theca interstitial 
cells (TICs) were isolated from the ovaries following the procedures described by Hoang et al 
(2013). Briefly, ovarian follicles were punctured with needles to release granulosa cells (GCs) 
and oocytes. The remaining ovarian tissue was minced with a scalpel and digested in 100 
μL/ovary of M199 medium with 0.35 mg/mL collagenase type IA, 10 ug/mL DNase, and 10 
mg/mL BSA at 37
o
C for 30 minutes. After digestion, the tissue was centrifuged at 1,000 rpm for 
4 minutes then the medium was aspirated, and cells were resuspended in 5 mL fresh M199. 
Debris and oocytes were subsequently removed using 100- and 40-mm cell strainers. 
Discontinuous Percoll gradients were used to purify TICs following Magoffin and Erickson 
(1988). Primary TICs were cultured in culture plates (Falcon, Meylan Cedex, France) in HEPEs 
buffered M199 with 5% FCS for 24 h, followed by 24–48 h in serum-free medium containing 
0.1% bovine serum albumin (BSA). Cultures were maintained in a humidified air/CO2 
atmosphere at 37
0
C. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
6 
 
 
2.4. Antipsychotics cytotoxicity by MTT 
Following the manufacturer’s protocol, TICs were seeded (1x104 cells per well) in 96-
well plastic plates. After reaching confluence, cells were incubated for 4, 24 and 48 hrs in the 
presence of the test APs at concentrations of 0.1, 1, 10 and 100 µM or DMSO alone as a vehicle 
control. Each experiment was performed in triplicate with at least 3 wells of each drug 
concentration in each experiment. The MTT absorbance values were expressed as a percent of 
the vehicle control (defined as 100%) and the 50% inhibitory concentration (IC50) for each AP 
was determined.  
2.5. Caspase assay 
 For the apoptotic caspases, -3, -8 and -9, activity assays were carried out.  Cells were 
grown in six-well plates (10
6
 cells per well) and treated with IC50 of each AP (CPZ, 12µM; HAL, 
58µM; RIS’ 160µM; CLZ, 44µM) for 2 hrs. Following the manufacturer’s protocol, cells were 
harvested and centrifuged at 1000 rpm for 5 min and lysed in 50µl of chilled lysis buffer on ice 
for 10 mins. Cells were then centrifuged for 10 mins at 4°C. The supernatant (50 µl) was added 
to an equal volume of 2× reaction/dithiothreitol (DTT) buffer supplemented with the supplied 
caspase-3, -8 or -9 substrates and incubated at 37
0
C for 2 hrs. Samples were transferred to a 96-
well plate to measure the fluorescence intensities by a Synergy HT Fluoremeter (Bio-tek 
Instruments, Inc., Winooski, VT) at the appropriate excitation and emission wavelengths.  
2.6. Reactive oxygen species (ROSs) detection 
3,7-dichlorodihydrofluorescein diacetate (DCFDA) assay was used to detect the Changes 
in pattern of ROSs production in TICs under the effect of APs. TICs were treated with APs in 
both IC50s and 1 µM concentrations for 24-hrs then the assay was performed as described by our 
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group (Elmorsy et al., 2014). Experiments were performed in triplicate, with at least 3 wells for 
each treatment in each experiment. 
2.7. Measurement of total glutathione 
Glutathione levels were assessed in the isolated TICs according to methods described by 
Senft et al. (2000). Briefly, TICs were exposed to APs at their estimated IC50s and 1µM 
concentration. After 24 hrs, TICs were scraped in ice cold phosphate buffered saline (PBS) 
followed by centrifugation.  The pellets obtained were re-suspended in ice-cold lysis buffer and 
centrifuged at 15000 g for 5 mins to generate lysates and protein pellets. Lysate content of 
glutathione was quantified with an excitation/emission wavelength of 350/420 nm using the 
fluorescent substrate o-phthaladehyde (OPT). 
2.8. Lipid peroxidation assay 
Thiobarbituric acid (TBA)-reactive products were assayed as a markers of Lipid 
peroxidation (Armostrong and Brown, 1994). Briefly, TICs were treated with APs at their IC50s 
and 1 µM concentrations for 24-hrs. Then media were removed and cells were harvested, 
counted and resuspended in phosphate buffer saline (PBS) at a density of 10
6
 cells/ml. Half a ml 
of PBS  was added to 0.5 ml of 30% (w/v) trichloroacetic acid containing 1 mM butylated 
hydroxytoluene. The samples were kept on ice for 30 mins and centrifuged at 1000g for 10 min. 
Then 700 µl of the supernatant was added to an equal volume of TBA (182 mg/25 ml) and 
heated to 100°C for 15 min. The samples were then cooled and absorbance read at 535nm 
(Ottolenghi, 1959).  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
8 
 
 
2.9. Effect of antioxidants on APs-induced cytotoxicity 
MTT assay was repeated in APs-treated TICs after adding 5mM reduced glutathione 
(GSH) and quercetin (50mM). 
2.10. Statistical analysis 
For IC50 estimation and non-linear curve fitting log (inhibitors)- variable slope equation 
was used. For comparisons, one way ANOVA test was used with Dunnett’s multiple 
comparisons post-test. Statistical analysis was conducted using PRISM 5 (GraphPad Software 
Inc., San Diego, CA) with statistical significance defined as P<0.05.  
3. Results 
3.1. Antipsychotics and TICs viability 
The MTT assay showed all APs to impair viability of TICs in a concentration and duration 
dependent manner (Fig 1). According to the estimated IC50 values, CPZ was the most potent, 
while RIS was the least toxic with the highest IC50 (Table 1). TICs viability was significantly 
decreased after four hours post-exposure to a concentration of 1 µM of CPZ (p=0.008) and CLZ 
(p=0.02). 
3.2. Antipsychotics and caspases in HMVECS 
As shown in Figure 2, Flourometric assay revealed a significant increase in caspases 3, 8 
and 9 in TICs treated with IC50s of three APs including CPZ (p<0.0001), HAL (P<0.0001) and 
CLZ (P<0.01).  There was no change in caspases activities in TICs treated with RIS (Fig 3). 
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3.3. Antipsychotics and ROS production 
DCFDA assay showed significantly increased release of ROS in TICs treated with all 
APs at their IC50s (P<0.0001). Only typical preparations CPZ and HAL in 1µM concentrations 
resulted in significant increase in ROS after 24hrs post-treatment (Dunnett’s multiple 
comparison post test) (Fig 3A). 
3.4. APs and TICs intracellular total glutathione 
As shown in Figure 3A, intracellular total glutathione significantly (P< 0.001) decreased 
in TICs treated with all APs in their IC50s compared to TICs treated with vehicle control. In 1µM 
concentrations, only typical preparations (CPZ and HAL), significantly decreased glutathione 
after 24-hrs exposure (Fig 3B).  
3.5. Antipsychotics and lipid peroxidation in TICs 
The lipid peroxidation assay showed TBA-reactive products to significantly (P<0.0001) 
increase in TICs treated with all tested APs (Fig 3C). Dunnet's posttest showed that all APs 
significantly increased LPO (P<0.001) in their IC50s, while only the typical preparations in 1µM 
concentration significantly (CPZ, p<0.05; HAL, P<0.01) increased LPO in TICs after 24-hrs (Fig 
2C). 
3.6. Antioxidants and APs-induced cytotoxicity 
MTT assay showed anti-oxidants (reduced GSH (5mM) or quercetin (50 mM)) to 
significantly decrease the cytotoxic effects of all tested APs in their IC50s (CPZ, P<0.0001; HAL, 
P<0.01; RIS, P<0.01; and CLZ, P<0.0001) (Figure 4). Reduced GSH (5mM) at a concentration 
of 1µM significantly decreased the cytotoxic effect of CPZ (P=0.0175) with no effect on 
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cytotoxicity of other APs. Quercetin at a 1µM concentration showed no effect on the cytotoxicity 
of any AP (Fig 4). 
 
4. Discussion 
To the best of our knowledge, this is the first study to investigate the role of oxidative 
stress in APs-induced reproductive toxicity. We found APs to induce cytotoxic effects on rat’s 
TICs as shown by the impairment of TICs viability and increased caspases activities. We have 
also shown APs  to induce oxidative stress as evidenced by increased ROSs production, 
decreased intracellular total glutathione and increased lipid peroxidation. Finally, we have shown 
for the first time that antioxidants can inhibit the cytotoxic effects of the APs on rat’s TICs.   
We have chosen rat’s TICs to test our hypothesis as they have been shown to be a valuable in-
vitro model for evaluating the safety of chemicals (Roberts, 2001) and are known to play an 
important role in ovarian steroidogenesis (Young and McNeilly, 2010).  
For the MTT assay, we used a wide range of APs concentrations including 0.1, 1, 10 and 
100µM. These concentrations were chosen as they correspond to therapeutic, hyper-therapeutic 
and toxic serum levels of APs in human  (Winek et al., 2001; Van Putten et al.,1991; Chang et 
al., 1997; Chang et al., 1994). Therapeutic serum levels were previously reported as 0.01-0.5 
mg/l (0.03-1.5 µM) for CPZ, 0.1-0.7 mg/l  (0.3–2µM) for CLZ, 0.006-0.24 mg/l (0.016-0.64 
µM) for  HAL and 0.003-0.12 mg/l (0.007–0.28 µM) for RIS (Winek et al., 2001). Overdose 
serum concentrations were 3mM for CPZ (Van Putten et al.,1991), 5mM for CLZ (Chang et al., 
1997), 0.7mM for HAL (Chang et al., 1994) and for RIS 0.5–0.8mM (220 to 320 ng/mL ng/ml; 
Titier et al., 2003; Nishikage et al., 2002). We have used higher concentrations in order to 
accelerate the effects and to define the IC50 values. We examined APs–induced cytotoxicity 
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48hrs after exposure as it was previously reported that APs take at least 48hrs to achieve 
maximum effect on cell viability (Erik et al., 2010).  
4.1. Antipsychotics cytotoxicity to rat’s TICs 
 Our MTT assay results are in agreement with several previous studies investigating 
APs effects on non-reproductive cells (Dwyer et al., 2003, Dwyer et al., 2005; Ardizzone et al., 
2001; Elmorsy et al., 2014; Hampson, 2000; Bhatt and Saleem, 2004; Ahn et al., 2004; Marlowe, 
2000). Regarding our IC50s data, CPZ was the most potent followed by CLZ. These findings are 
in agreement with previous studies investigating the effects of these APs on pC12 cell line 
(Dwyer et al., 2003) and on normal human fibroblast (Jones-Brando et al., 2003).  
4.2 Antipsychotics and Caspases  
In this study, APs-induced cytotoxic effect on TICs was associated with increased 
apoptotic caspases activity. It is well known from recent studies that oxidative stress plays a 
pivotal role in induction of apoptosis. Antioxidants such as  the thiol reducing agent N-
acetylcysteine have been found to block or delay apoptosis (Buttke and Sandstrom, 1994; 
Kannan and Jain 2000). We have investigated caspases activity in this study as a marker of 
cytotoxicity as well as oxidative stress. Our findings, therefore, provide further evidence to 
support our hypothesis that APs-induced oxidative stress may play a role in ovarian cytotoxicity 
by inducing apoptosis.  
Our data on the effects of APs on caspases are consistent with previous studies 
investigating the effects of APs on non-reproductive cells. HAL was reported to increase 
caspase-3 activity in human neuroblastoma SK-N-SH cells (Gassó et al., 2012) and CPZ 
increased apoptosis in lymphoblasts by (Hieronymus et al., 2003). In addition. Elmorsy et al. 
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(2014) reported increased caspases -3, -8 and -9 activities in human microvascular endothelial 
cells of blood brain barrier in response to a 24-hours exposure to CPZ, HAL and CLZ.  
4.3. Antipsychotics and Oxidative stress  
Our data on the effect of APs on ROSs production are in agreement with previous in-
vitro studies investigating APs effects on non-reproductive cells. We have previously reported 
increased ROSs production in human microvascular endothelial cells of blood brain barrier 24-
hrs after exposure to CPZ, HAL, RIS and CLZ. (Elmorsy et al., 2014). Antherieu et al (2013) 
showed CPZ to induce oxidative stress in human hepatoma HepaRG cells.  Similarly, Contreras-
Shannon et al (2013) found CLZ to induce oxidative stress in several non-reproductive mouse 
cell lines; myoblasts (C2C12), adipocytes (3T3-L1), hepatocytes (FL-83B), and monocytes 
(RAW 264.7).  
Our findings are also consistent with several earlier in-vivo studies investigating APs-
induced oxidative stress in human (Shivakumar and Ravindranath, 1992) as well as in animals 
(Parikh et al., 2003 and Raudenska et al., 2013). Shivakumar and Ravindranath (1992) reported 
decreased human serum antioxidant enzyme activity after chronic treatment with HAL. Parikh et 
al (2003) and Martins et al (2008) provided evidence of oxidative stress in Wistar rat brain after 
chronic treatment with HAL.  
 
4.4 Implications and clinical relevance 
The protective effect of both antioxidants on the APs-induced cytotoxicity supports our 
hypothesis that oxidative stress plays a role in reproductive toxicity. Oxidative stress may 
therefore be a good therapeutic target for the management of the troublesome reproductive 
adverse reproductive effects of APs. In addition, antioxidant therapy may be beneficial in 
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treating APs overdose and toxicity. Further clinical research is required to investigate the clinical 
usefulness of antioxidants in patients receiving antipsychotic therapy.  
Conclusion 
Oxidative stress seems to be a possible mechanism for APs-induced ovarian cytotoxicity 
with subsequent reproductive dysfunction. The protective effects of antioxidants on this ovarian 
cytotoxicity may pave the way for the development of an effective therapy to counteract the 
reproductive as well as other adverse effects of antipsychotics.     
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Figure legends  
Figure (1): MTT study of the effect of APs on viability of rats isolated ovarian TICs. Viability was 
expressed as a percentage of the vehicle control. Data are shown as mean ± S.E.M (n=x-y). Solid 
lines are  fitted to a four parameter logistic equation given in the materials and methods 
section. 
 
Figure (2):  Flourometric assay of caspases -3, -8 and -9 activities in rats isolated ovarian TICs 
treated with APs CPZ, HAL, RIS and CLZ.  Significance is relative to vehicle. Values are 
represented as means (± S.E.M; n=9). P-values were estimated by one way ANOVA test with 
Dunnett’s multiple comparison post-test to test the significance of difference from the control. 
(* indicate p-value <0.05, ** indicate p-value <0.01, and *** indicate p < 0.001 when compared 
with vehicle control treated group). 
 
Figure (3): The effect of antipsychotics on isolated rats TICs ROSs production [A]. intracellular 
total glutathione intracellular total glutathione [b] and LPO products [C]. Samples were 
compared statistically with the vehicle samples using one way ANOVA with Dunnett’s post-test. 
Data are represented as percentages of the vehicle control treated samples assuming that the 
vehicle control readings are equal to 100%. (* indicates p-value <0.05, ** indicate p-value 
<0.01, and *** indicate p < 0.001 when compared with vehicle control treated group). 
 
Figure (4):  Effect of reduced glutathione (5mM) and quercetin (50mM) on APs-induced 
cytotoxicity in rats isolated ovarian TICs. Readings for MTT absorbance of the treated samples 
(in absence or presence of reduced GSH or quercetin) were compared statistically with the 
vehicle samples using one way ANOVA with Dunnett’s post-test. (* indicates p-value <0.05, ** 
indicate p-value <0.01, and **** indicate p < 0.0001 when compared with vehicle control 
treated group). 
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Fig. 2 
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Fig. 3 
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Fig. 4 
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Table (1) MTT assay estimated IC50 of antipsychotic-induced cytotoxic effect on rat isolated 
ovarian TICs.  IC50s were estimated by log inhibitors versus response (variable slope) equation. 
IC50s are represented as means (M), upper limit (UL) and lower limit (LL) of 95% confidence 
interval.  
 
Exposure 
Duration 
CPZ HAL RIS CLZ 
M UL LL M UL LL M UL LL M UL LL 
4hrs 13 19 9.5 93 152 76 84 168 45 26 78 7.6 
24hrs 12 19 9.5 58 76 38 73 160 30 22 44 11 
48hrs 1 13 7.7 40 76 38 67 114 38 18 29 11 
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The role of oxidative stress in antipsychotics induced ovarian toxicity 
Highlights: 
- Antipsychotics are cytotoxic to ovarian theca cells in a concentration dependent manner. 
- Typical antipsychotics are more cytotoxic than atypical antipsychotics to the ovarian theca cells. 
- Oxidative stress plays an important role in antipsychotics-induced ovarian cytotoxicity 
- Antioxidants are proposed to alleviate antipsychotics-induced reproductive dysfunction. 
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